61 related articles for article (PubMed ID: 8409600)
1. [A clinical and experimental study of the antithrombotic percutaneous cardiopulmonary support using the new antithrombotic coating material].
Kawahito K
Nihon Kyobu Geka Gakkai Zasshi; 1993 Sep; 41(9):1467-77. PubMed ID: 8409600
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antithrombogenicity of a new microdomain structured copolymer.
Kawahito K; Tasai K; Murata S; Yamaguchi A; Mizuhara A; Adachi H; Ino T
Artif Organs; 1995 Aug; 19(8):857-63. PubMed ID: 8573009
[TBL] [Abstract][Full Text] [Related]
3. [In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer].
Matsumoto S; Yamada Y; Kiyosue H; Dono S; Mori H; Imagawa M; Nomura Y; Toyoda H; Shimada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):238-43. PubMed ID: 9164111
[TBL] [Abstract][Full Text] [Related]
4. [A clinical experience of V-A bypass using a new antithrombotic coating material].
Kawahito K; Ino T; Ide H; Adachi H; Mizuhara A; Yamaguchi A
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jul; 40(7):1110-5. PubMed ID: 1506705
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of a fluorine-acryl-stylene-urethane-silicone antithrombogenic coating material copolymer for intravascular stents.
Matsuhashi T; Miyachi H; Ishibashi T; Sakamoto K; Yamadera A
Acad Radiol; 1996 Jul; 3(7):581-8. PubMed ID: 8796720
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
von Segesser LK; Turina M
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
[TBL] [Abstract][Full Text] [Related]
7. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats.
Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H
Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115
[TBL] [Abstract][Full Text] [Related]
10. [An experimental study of a newly developed silicone coated membrane oxygenator].
Iida M
Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):700-10. PubMed ID: 9170861
[TBL] [Abstract][Full Text] [Related]
11. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
12. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
13. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit].
Takano H; Miyamoto Y; Kaneko M; Matsuwaka R; Kuratani T; Amemiya A; Nakano S; Matsuda H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Nov; 41(11):2166-73. PubMed ID: 8283086
[TBL] [Abstract][Full Text] [Related]
16. Can protamine be used during perfusion with heparin surface coated equipment?
von Segesser LK; Gyurech DD; Schilling JJ; Marquardt K; Turina MI
ASAIO J; 1993; 39(3):M190-4. PubMed ID: 8268526
[TBL] [Abstract][Full Text] [Related]
17. [Long-term application of percutaneous cardiopulmonary support system without systemic heparinization].
Miura M; Fukuju T
Kyobu Geka; 2004 Feb; 57(2):115-8. PubMed ID: 14978904
[TBL] [Abstract][Full Text] [Related]
18. Heparin coated percutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery.
Kawahito K; Ino T; Adachi H; Ide H; Mizuhara A; Yamaguci A
ASAIO J; 1994; 40(4):972-6. PubMed ID: 7858334
[TBL] [Abstract][Full Text] [Related]
19. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
